Mukund Mohan Desai

Mukund Mohan Desai

Active Director Additional Director DIN 02831408
DIN 02831408 First appointment Feb 2014 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2014
Shareholding value β€’β€’β€’β€’ Premium profile

About Mukund Mohan Desai

Data last updated:

Mukund Mohan Desai is an Additional Director at Mcmurry Biopharmachem Private Limited (since 2014). The company operates in Chemicals.

DIN 02831408
Primary Designation Additional Director
Industry Chemicals
First Appointment 17 Feb 2014
Oldest Company Age 16 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director17 Feb 20142009Active

Board colleagues of Mukund Mohan Desai

NameDINCompanyDesignation
Ramesh Shankarrao More06601971Mcmurry Biopharmachem Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Mcmurry Biopharmachem Private Limited
Premium access

Shareholding and investment profile for Mukund Mohan Desai

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mukund Mohan Desai

Mukund Mohan Desai currently holds 1 directorship: Mcmurry Biopharmachem Private Limited (Additional Director, since 17 Feb 2014).

Mukund Mohan Desai was first appointed on 17 Feb 2014 as Additional Director at Mcmurry Biopharmachem Private Limited.

The current boards of Mukund Mohan Desai's companies include Ramesh Shankarrao More (Mcmurry Biopharmachem Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available